Feed MREO
MR
Mereo BioPharma Group plc
MREO · NASDAQ
$0.32 +6.26% (+$0.02)
1M +4.49%
Market Cap $50.9M
P/E Ratio -
Div. Yield -
ROE 85.94%
Bulios Fair Price
$0.44
38.0% upside
Preț actual
$0.32
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile MREO sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
50 /100
Fair P/B 1.24x
P/S 101.81x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 7.32%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Net margin 8,375.60%
Op. margin 7,651.40%
FCF margin 6,198.20%
Quality
0 /100
Poor ROE 85.94%
ROA 91.20%
Asset turnover 0.01x
Debt
69 /100
Low Current ratio 10.46x
Int. coverage -163.23x
Debt/Equity 0.00x
Stability
27 /100
Unstable EPS volatility 46.01%
Profitable years 0
Beta 0.29x
Întreabă StockBot despre MREO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Denise Vera Scots-Knight
Employees
39
Headquarters
London
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report